Found 475 results in Expert Content

This executive summary provides expert insight on overcoming manufacturing challenges associated with expedited development programs.

Summary: In this webinar, experts provide an overview of the latest trends in manufacturing of oral solid dosage form and discuss key considerations of transitioning an early-stage project to late-stage as well as technology transfer.

This executive summary includes evidence on how the right guidance at the right time can help you create more successful treatments.

Summary: This webinar will discuss how to classify HPAPIs in early development and share recommendations for safe product handling, from clinical manufacturing to commercialization.

Summary: Catalent is a global leader in pharmaceutical air jet milling micronization with more than 30 years’ experience delivering micronization solutions.

Summary: In this webinar a group of experienced cancer drug developers discusses key strategies in managing an orphan drug program.

Summary: This webinar discusses, key considerations of early drug development, molecule developability assessment, drug bioavailability and discussed the relationship between intracellular and transcellular permeability of beyond the Rule of Five drugs.

Summary: Using Zydis® orally dissolving tablet (ODT) platform from Catalent as a unique delivery route for allergy immunotherapies.

Summary: A growing number of drug launches have faltered at the final hour because manufacturing processes weren’t up to FDA standards. This webinar explores how drug developers can properly monitor quality throughout the clinical production process and fix any issues that arise—before the FDA brings out the red flags.

Summary: Learn more about the role of oral dose delivery for tolerogenic vaccines, fast dissolving tablets and biological APIs.